An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge-Reference-Cited by-同舟云学术

An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge

Published:2023-07 Issue:32 Volume:41 Page:4710-4718
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Honda-Okubo Yoshikazu^ORCID,Li Lei^ORCID,André Greiciely,Leong King Ho,Howerth Elizabeth W.,Bebin-Blackwell Anne G.,Ross Ted M.^ORCID,Petrovsky Nikolai^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference47 articles.

1. World Health Organisation. Weekly operational update on COVID-19 -20 September 2021; 2021. p. 1–16.

2. COVID-19 vaccines;Ndwandwe;Curr Opin Immunol,2021

3. Temperature concerns could slow the rollout of new coronavirus vaccines;Kaiser;Science,2020

4. COVID-19 vaccination in developing nations: challenges and opportunities for innovation;Sheikh;Infect Disease Reports,2021

5. A global database of COVID-19 vaccinations;Mathieu;Nat Hum Behav,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronavirus spike protein-based vaccines. Vaccine delivery systems;Medicine in Drug Discovery;2024-09

2. Clinical development of SpikoGen®, an Advax-CpG55.2 adjuvanted recombinant spike protein vaccine;Human Vaccines & Immunotherapeutics;2024-06-05

3. Comparative immunogenicity and safety of SpikoGen®, a recombinant SARS-CoV-2 spike protein vaccine in children and young adults: An immuno-bridging clinical trial;International Immunopharmacology;2024-01

4. Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants;Vaccine;2023-11

5. Developmental and reproductive safety of Advax-CpG55.2™ adjuvanted COVID-19 and influenza vaccines in mice;Vaccine;2023-09